Effects of ravuconazole treatment on parasite load and immune response in dogs experimentally infected with Trypanosoma cruzi

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 7, 2010, Pages 2979-2986

  Diniz, Lívia De Figueiredo ^a   Caldas, Ivo Santana ^a   Guedes, Paulo Marcos Da Matta ^a   Crepalde, Geovam ^a   De Lana, Marta ^a   Carneiro, Cláudia Martins ^a   Talvani, André ^a   Urbina, Julio Alberto ^b   Bahia, Maria Terezinha ^a  

^a FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

^b INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

BENZNIDAZOLE; GAMMA INTERFERON; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; INTERLEUKIN 10; MESSENGER RNA; RAVUCONAZOLE; ANTITRYPANOSOMAL AGENT; IMMUNOGLOBULIN G; THIAZOLE DERIVATIVE; TRIAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHAGAS DISEASE; CONTROLLED STUDY; DOG; DRUG EFFECT; DRUG TOLERABILITY; HUMORAL IMMUNITY; IMMUNE RESPONSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROLOGY; TREATMENT RESPONSE; ANIMAL; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; HEART MUSCLE; IMMUNOLOGY; METABOLISM; PARASITOLOGY; PATHOGENICITY; TRYPANOSOMA CRUZI;

ANIMALS; CHAGAS DISEASE; DOGS; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOGLOBULIN G; INTERFERON-GAMMA; INTERLEUKIN-10; MYOCARDIUM; POLYMERASE CHAIN REACTION; THIAZOLES; TRIAZOLES; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI;

EID: 77953742894     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01742-09     Document Type: Article

References (30)

1. Andes, D., K. Marchillo, T. Stamstad, and R. Conklin. 2003. In vivo pharmacodynamics of a new triazole, ravuconazole, in a murine candidiasis model. Antimicrob. Agents Chemother. 47:1193-1199.
2. Braga, M. S., L. Lauria-Pires, E. R. Argañaraz, R. J. Nascimento, and A. R. L. Teixeira. 2000. Persistent infections in chronic Chagas' disease patients treated with anti-Trypanosoma cruzi nitroderivatives. Rev. Inst. Med. Trop. Sao Paulo 42:157-161.
3. Britto, C., M. A. Cardoso, P. Wincker, and C. M. Morel. 1993. A simple protocol for the physical cleavage of Trypanosoma cruzi kinetoplast DNA present in blood samples and its use in polymerase chain reaction (PCR)-based diagnosis of chronic Chagas disease. Mem. Inst. Oswaldo Cruz 88:171-172.
4. Buckner, F. S., J. H. Griffin, A. J. Wilson, and W. C. Van Voorhis. 2001. Potent anti-Trypanosoma cruzi activities of oxidosqualene cyclase inhibitors. Antimicrob. Agents Chemother. 45:1210-1215.
5. Caldas, I. S., A. Talvani, S. Caldas, C. M. Carneiro, M. Lana, P. M. Guedes, and M. T. Bahia. 2008. Benznidazole therapy during acute phase of Chagas disease reduces parasite load but does not prevent chronic cardiac lesions. Parasitol. Res. 103:413-421.
6. Cançado, J. R. 2002. Long term evaluation of etiological treatment of Chagas disease with benznidazole. Rev. Inst. Med. Trop. Sao Paulo 44:29-37.
7. Chiari, E., J. C. Dias, M. Lana, and C. A. Chiari. 1989. Hemocultures for the parasitological diagnosis of human chronic Chagas' disease. Rev. Soc. Bras. Med. Trop. 22:19-23.
8. Cunha-Neto, E., P. C. Teixeira, L. G. Nogueira, C. Mady, B. Lanni, N. Stolf, A. Fiorelli, R. Honorato, and J. Kalil. 2007. New concepts on the pathogenesis of chronic Chagas cardiomyopathy: myocardial gene and protein expression profiles. Rev. Soc. Bras. Med. Trop. 39:59-62.
9. Dias, J. C. 2007. Globalization, inequity and Chagas disease. Cad. Saude Publica 23:13-22.
10. Gomes, M. L., A. M. Macedo, A. R. Vago, S. D. Pena, L. M. Galvão, and E. Chiari. 1998. Trypanosoma cruzi: optimization of polymerase chain reaction for detection in human blood. Exp. Parasitol. 88:28-33.
11. Guedes, P. M., J. A. Urbina, M. Lana, L. C. C. Afonso, V. M. Veloso, W. L. Tafuri, G. L. Machado-Coelho, E. Chiari, and M. T. Bahia. 2004. Activity of the new triazole derivative albaconazole against Trypanosoma (Schizotrypanum) cruzi in dog hosts. Antimicrob. Agents Chemother. 48:4286-4292.
12. Guedes, P. M., V. M. Veloso, L. C. C. Afonso, M. V. Caliari, C. M. Carneiro, L. F. Diniz, E. A. Marques-da-Silva, I. S. Caldas, M. A. Do Valle Matta, S. M. Souza, M. Lana, E. Chiari, L. M. Galvão, and M. T. Bahia. 2009. Development of chronic cardiomyopathy in canine Chagas disease correlates with high IFN-gamma, TNF-alpha, and low IL-10 production during the acute infection phase. Vet. Immunol. Immunopathol. 130:43-52.
13. Guedes, P. M., V. M. Veloso, J. K. Gollob, L. C. C. Afonso, I. S. Caldas, P. Vianna, M. Lana, E. Chiari, M. Bahia, and L. M. C. Galvão. 2008. IgG isotype profile is correlated with cardiomegaly in beagle dogs infected with distinct Trypanosoma cruzi strains. Vet. Immunol. Immunopathol. 124:163-168.
14. Guedes, P. M., V. M. Veloso, W. L. Tafuri, L. M. Galvão, C. M. Carneiro, M. Lana, E. Chiari, K. Ataide Soares, and M. T. Bahia. 2002. The dog as model for chemotherapy of the Chagas' disease. Acta Trop. 84:9-17.
15. Lauria-Pires, L., M. S. Braga, A. C. Vexenat, N. Nitz, A. Simões-Barbosa, D. L. Tinoco, and A. R. L. Teixeira. 2000. Progressive chronic Chagas heart disease ten years after treatment with anti-Trypanosoma cruzi nitroderivatives. Am. J. Trop. Med. Hyg. 63:111-118.
16. Maltos, K. L., G. B. Menezes, M. V. Caliari, O. A. Rocha, J. M. Santos, D. L. Alves, I. D. Duarte, and J. N. Francischi. 2004. Vascular and cellular responses to pro-inflammatory stimuli in rat dental pulp. Arch. Oral Biol. 49:443-450.
17. Marin-Neto, J. A., E. Cunha-Neto, B. C. Maciel, and M. V. Simões. 2007. Pathogenesis of chronic Chagas heart disease. Circulation 115:1109-1123.
18. Mikamo, H., X. H. Yin, Y. Hayasaki, Y. Shimamura, K. Uesugi, N. Fukayama, M. Satoh, and T. Tamaya. 2002. Penetration of ravuconazole, a new triazole antifungal, into rat tissues. Chemotherapy 48:7-9. (Pubitemid 34233878)
19. Molina, J. T., Z. Brener, J. A. Urbina, and A. J. Romanha. 2000. Activity of TAK-187 triazole on mice infected with Trypanosoma cruzi strains differently susceptible to benznidazole. Mem. Inst. Oswaldo Cruz 95:304-308.
20. Moncayo, A. 2003. Chagas disease: current epidemiological trends after the interruption of vectorial and transfusional transmission in the Southern Cone countries. Mem. Inst. Oswaldo Cruz 98:577-591.
21. Pascuti, M. F., M. Pitashny, A. L. Nocito, P. Guermonprez, S. Amigorena, J. Wietzerbin, E. Serra, O. Bottasso, and S. Revelli. 2004. Benznidazole, a drug used in Chagas' disease, ameliorates LPS-induced inflammatory response in mice. Life Sci. 76:685-697.
22. Tarleton, R. L. 2001. Parasite persistence in the aetiology of Chagas disease. Int. J. Parasitol. 31:550-554.
23. Urbina, J. A. 2009. Ergosterol biosynthesis and drug development for Chagas disease. Mem. Inst. Oswaldo Cruz 104:311-318.
24. Urbina, J. A., G. Payares, C. Sanoja, J. Molina, R. Lira, Z. Brener, and A. J. Romanha. 2003. In vitro and in vivo activities of ravuconazole on Trypanosoma cruzi, the causative agent of Chagas disease. Int. J. Antimicrob. Agents 21:27-38.
25. Urbina, J. A., J. L. Concepcion, A. Caldera, G. Payares, C. Sanoja, T. Otomo, and H. Hiyoshi. 2004. In vitro and in vivo activities of E5700 and ER-119884, two novel orally active squalene synthase inhibitors, against Trypanosoma cruzi. Antimicrob. Agents Chemother. 48:2379-2387.
26. Urbina, J. A., K. Lazardi, E. Marchan, G. Visbal, T. Aguirre, M. M. Piras, R. Piras, R. A. Maldonado, G. Payares, and W. de Souza. 1993. Mevinolin (lovastatin) potentiates the antiproliferative effects of ketoconazole and terbinafine against Trypanosoma (Schizotripanum) cruzi: in vitro and in vivo studies. Antimicrob. Agents Chemother. 37:580-591.
27. Urbina, J. A., and R. Docampo. 2003. Specific chemotherapy of Chagas disease: controversies and advances. Trends Parasitol. 19:495-501.
28. Viotti, R., C. Vigliano, H. Armenti, and E. Segura. 1994. Treatment of chronic Chagas disease with benznidazole: clinical and serological evolution of patients with long-term follow-up. Am. Heart J. 127:151-162.
29. Voller, A., D. E. Bidwell, and A. Bartlett. 1976. Enzyme immunoassays in diagnostic medicine. Theory and practice. Bull. World Health Organ. 53:55-65.
30. WHO. 2007. Report of Scientific Group in Chagas Disease. Update July 2007. Special Programme for Research and Training in Tropical Diseases, WHO, Geneva, Switzerland.